Aclarion, Inc. (ACON)
Nasdaq: ACON · Services-Medical Laboratories · Broomfield, CO · filing with the SEC since 2015
Who runs Aclarion, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ness Brent
Chief Executive Officer. First filing Apr 2022, latest Aug 17, 2026, 5 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
10 people on the record since 2022
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gould Gregory A | CFO | Sep 2025 | Aug 18, 2026 | none |
| Ness Brent | Chief Executive Officer | Apr 2022 | Aug 17, 2026 | none |
| Bond Ryan | Chief Strategy Officer | Apr 2022 | Aug 17, 2026 | none |
| Thramann Jeffrey John | Executive Chairman | Apr 2022 | Jun 12, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Sequira Amanda Mae | director | Apr 2022 | Aug 19, 2026 | none |
| Neal David K | director | Apr 2022 | Aug 17, 2026 | none |
| Wesemann William | director | Apr 2022 | Aug 17, 2026 | none |
| Breidbart Scott | director | Apr 2022 | Jun 12, 2026 | none |
| Deitsch Stephen | director | Apr 2022 | Jun 12, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.